HeXun Biosciences Co., Ltd. (6986.TWO)

TWD 76.7

(-1.29%)

Market Cap (In TWD)

3.52 Billion

Revenue (In TWD)

130.57 Million

Net Income (In TWD)

33.48 Million

Avg. Volume

125.77 Thousand

Currency
TWD
Country
-
Open
-
Prev. Close
-
Day Range
-
Year Range
40.0-85.3
PE
-
EPS
-
Beta Value
0.0
ISIN
TW0006986003
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Industry
-
CEO
-
Employee Count
-
Website
https://www.hexunbio.com
Ipo Date
2023-09-07
Details
HeXun Biosciences Co., Ltd. engages in the research and development of stem cell and treatments in Taiwan. It provides outsourced production services; commissioned development and manufacturing services for various cells and cell derivatives; commissioned inspection; advisory; laboratory information management system; and sterile filling services. The company was founded in 2019 and is based in Taoyuan City, Taiwan.